Spravato (Esketamine)
esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations · NASAL · PBS code 14837X
AUTHORITY_REQUIREDWhat it costs
AU$294.16 PBS-determined price per 8 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2025-05-01.
- • Repeats: 5.
- • PBS program: HB.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Treatment resistant major depression
Non-induction treatment
The treatment must be to continue existing PBS-subsidised treatment for this indication; AND
The treatment must not exceed each of: (i) an administered dose beyond 84 mg, (ii) a quantity of drug, after accounting for repeat prescriptions plus different pack sizes where prescribed, that would exceed a quantity sufficient to treat the patient for 24 weeks; AND
Patient must have demonstrated adequate response to treatment with esketamine after the 4-week induction and every 6 months thereafter as evaluated by a structured clinical rating scale (evidence of scores and justification of demonstration of response must be retained in the patient's medical records); AND
Must be treated by a psychiatrist, where prescribing must also be completed by the treating psychiatrist; AND
Patient must be undergoing supervision at an accredited treatment centre for the administration of esketamine.
The listed quantity of 8 units of nasal spray is intended for a dosage of 56 mg per treatment administration in the non-induction treatment setting.
Sponsor: Janssen-Cilag Pty Ltd ABN 47 000 129 975
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.